US Broker Ratings

HCA Healthcare, Inc. (HCA) Stock Analysis: Evaluating a Healthcare Powerhouse with 18% Potential Upside

HCA Healthcare, Inc. (NYSE: HCA), a leading player in the medical care facilities industry, commands significant attention from investors as it stands at the intersection of healthcare necessity and financial..

ICON plc (ICLR) Stock Analysis: Navigating the Healthcare Sector with a 13.79% Potential Upside

ICON plc (NASDAQ: ICLR), a leading clinical research organization headquartered in Dublin, Ireland, has captured the attention of investors with its robust strategic offerings in the healthcare sector. As a..

Exact Sciences Corporation (EXAS) Investor Outlook: High Growth Potential with 41% Upside

Exact Sciences Corporation (NASDAQ: EXAS), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, has caught the attention of investors with its robust growth prospects..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 6.14% Upside Potential in the Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC), a dominant player in the healthcare sector, particularly in medical distribution, is attracting investor attention with a market cap of $8.93 billion. Operating globally, Henry..

Humana Inc. (HUM) Stock Analysis: Exploring a 19.91% Potential Upside Amid Strong Revenue Growth

Investors looking to explore opportunities within the healthcare sector may find Humana Inc. (NYSE: HUM) a compelling prospect. As a well-established player in the healthcare plans industry, Humana boasts a..

DexCom, Inc. (DXCM) Stock Analysis: Unpacking the 11.65% Upside Potential for Investors

DexCom, Inc. (NASDAQ: DXCM), a prominent player in the healthcare sector, specializes in the medical devices industry, focusing on continuous glucose monitoring (CGM) systems. With a market capitalization of approximately..

Walgreens Boots Alliance, Inc. (WBA) Stock Analysis: Navigating Challenges with an 8.61% Dividend Yield

Investors eyeing Walgreens Boots Alliance, Inc. (NASDAQ: WBA) are presented with a complex picture. As a major player in the healthcare sector, specifically within the pharmaceutical retail industry, Walgreens Boots..

McKesson Corporation (MCK) Investor Outlook: Navigating a 9.40% Upside Potential

McKesson Corporation (NYSE: MCK), an integral player in the healthcare sector, exemplifies resilience and adaptability in the ever-evolving landscape of medical distribution. With a market capitalization of $88.91 billion, McKesson..

Investor Outlook: The Cooper Companies, Inc. (COO) Shows 25% Potential Upside Amid Solid Buy Ratings

Investors seeking opportunities in the healthcare sector might find The Cooper Companies, Inc. (NYSE: COO) intriguing, as it offers a compelling investment case with a notable 25.04% potential upside based..

Exelixis, Inc. (EXEL) Stock Analysis: A Biotech Powerhouse with a 30% Revenue Growth Surge

Exelixis, Inc. (NASDAQ: EXEL), a notable player in the biotechnology sector, continues to capture investor attention with its remarkable revenue growth of 30.60%. The company, headquartered in Alameda, California, specializes..

Edwards Lifesciences Corporation (EW) Stock Analysis: Exploring a 6.36% Potential Upside for Investors

Edwards Lifesciences Corporation (NYSE: EW), a leading name in the healthcare sector, presents an intriguing opportunity for investors with a 6.36% potential upside. As a key player in the medical..

Insulet Corporation (PODD) Stock Analysis: Strong Buy Ratings Highlight 17.2% Potential Upside

Insulet Corporation (NASDAQ: PODD), a prominent player in the healthcare sector specializing in medical devices, is capturing significant attention in the investment community. With a market capitalization of $20.42 billion,..

Veeva Systems Inc. (VEEV) Stock Analysis: Exploring Growth Potential and Analyst Ratings

Veeva Systems Inc. (NYSE: VEEV), a leader in providing cloud-based software solutions tailored for the life sciences sector, is capturing attention with its strategic growth trajectory and robust analyst ratings...

Genmab A/S (GMAB) Stock Analysis: A 31% Upside Potential in the Biotech Sector

Genmab A/S (GMAB), a prominent player in the biotechnology sector, stands out with its robust portfolio of antibody-based products targeting cancer and other serious diseases. Headquartered in Copenhagen, Denmark, this..

Encompass Health Corporation (EHC) Stock Analysis: 22% Upside Potential and Robust Revenue Growth

Encompass Health Corporation (NYSE: EHC), a prominent player in the healthcare sector, shines in the medical care facilities industry with a market capitalization of $10.85 billion. Headquartered in Birmingham, Alabama,..

Royalty Pharma plc (RPRX) Stock Analysis: A 14.94% Potential Upside Beckons Investors

Royalty Pharma plc (NASDAQ: RPRX) represents a unique opportunity in the biotechnology sector for investors seeking exposure to the healthcare industry with a focus on biopharmaceutical royalties. With a market..

The Cigna Group (CI): Investor Outlook on a Healthcare Giant with 26.5% Upside Potential

For investors eyeing opportunities in the healthcare sector, The Cigna Group (NYSE: CI) stands out as a formidable player. With a substantial market capitalization of $79.17 billion, this U.S.-based healthcare..

Natera, Inc. (NTRA) Stock Analysis: Diagnostic Innovator with a 38.79% Upside Potential

Natera, Inc. (NASDAQ: NTRA), a key player in the healthcare sector, operates within the diagnostics and research industry with an impressive market capitalization of $18.97 billion. As a molecular diagnostics..

UnitedHealth Group (UNH): Valuation Insights and Growth Potential Amidst Healthcare Sector Dynamics

UnitedHealth Group Incorporated (NYSE: UNH) stands as a formidable player in the healthcare plans industry, with a market capitalization of $254.96 billion. As a cornerstone in the U.S. healthcare landscape,..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 13.95% Potential Upside in the Diagnostics & Research Sector

Agilent Technologies, Inc. (NYSE: A), a key player in the healthcare sector, particularly within the diagnostics and research industry, presents a compelling case for investors seeking opportunities in this dynamic..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds